TCR-mediated activation in vitro results in a profound loss of CD8 and subsequent apoptosis in MAIT cells [29], and this process may be accelerated in the tumor microenvironment, where an impaired epithelial barrier allows influx of bacterial metabolites [35, 36]. This evidence concerns the gene CD8A and neoplasm.